Bantam Pharmaceutical Presents New Preclinical Data for BTM-3566 at the American Association for Cancer Research (AACR) Annual Meeting 2025
Hand-out
Press Releases
Bantam Pharmaceutical, LLC  
April 25, 2025

Bantam Pharmaceutical Presents New Preclinical Data for BTM-3566 at the American Association for Cancer Research (AACR) Annual Meeting 2025

• BTM-3566 shows solid tumor regression and identifies FAM210B as a potential biomarker for response and combination strategies

logo salamanca press

Salamanca Press

Local & Social